NCT07241845Not yet recruiting
Epiretinal Membrane in Patients With DR.
Epiretinal Membrane in Patients With Diabetic Retinopathy.
Source: ClinicalTrials.gov · Last updated 21 Nov 2025
Brief summary (registry, in English)
To report the prevalence of ERM among patients with diabetic retinopathy, and the possible associated risk factors.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 225 (estimated)
- First submitted
- 17 Nov 2025
- Start date
- Jan 2026
- Primary completion date
- Jan 2028
- Lead sponsor
- Assiut University
- Diseases
- Diabetic eye disease
- NCT number
- NCT07241845
What you commit to
- Study type: Observational
- Planned participants: 225
- From Jan 2026 to the primary completion date, Jan 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- • History of previous eye trauma or surgery other than uneventful cataract surgery, uveitis, history of retinal detachment, media opacity impairing the quality OCT images, high myopia, macular or retinal diseases disease affecting the visual acuity other than diabetic retinopathy, e.g. macular hole, retinitis pigmentosa, AMD, CRVO.
Who the study is looking for
- Patients aged 18 years or older.
- Patients with ERM confirmed by OCT images.
- Patients with DM with varying severity of diabetic retinopathy.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.